Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Entity in Clinical Practice

Area of Science:

• Hematology
• Oncology
• Immunophenotyping

Background:

• Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy.
• It is classified under histiocytic/dendritic cell neoplasms in the WHO classification.
• BPDCN is known for its aggressive nature and complex clinical presentation.

Observation:

• An 85-year-old female with rheumatoid arthritis presented with constitutional symptoms including low-grade fever, anorexia, and weight loss.
• Symptoms had been present for one month prior to presentation.
• Diagnostic workup included immunophenotyping of a bone marrow aspirate.

Findings:

• Immunophenotyping confirmed the diagnosis of Blastic plasmacytoid dendritic cell neoplasm (BPDCN).
• The case highlights the diagnostic challenges associated with BPDCN.
• The patient's complex medical history potentially influenced the presentation and diagnostic process.

Implications:

• This case underscores the importance of considering rare hematologic malignancies in the differential diagnosis of unexplained constitutional symptoms.
• Early detection and accurate diagnosis are critical for timely and effective treatment of BPDCN.
• Interdisciplinary collaboration among healthcare professionals is essential for optimizing patient care and outcomes in BPDCN.